Dual function of MG53 in membrane repair and insulin signaling

BMB Reports

Volumn 49, Issue 8, 2016, Pages 414-423

  Tan, Tao ^a   Ko, Young Gyu ^b   Ma, Jianjie ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Korea University   (South Korea)

Author keywords

E3 ligase; Insulin resistance; Membrane repair; MG53; Muscular dystrophy; TRIM72

Indexed keywords

INSULIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; GENETICS; HUMAN; METABOLISM; PROTEOMICS; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WOUND HEALING;

ANIMALS; HUMANS; INSULIN; MUSCLE, SKELETAL; PROTEOMICS; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; WOUND HEALING;

EID: 84992348957     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2016.49.8.079     Document Type: Review

References (89)

1. Eriksson JG (1999) Exercise and the treatment of type 2 diabetes mellitus. An update. Sports Med 27, 381-391
2. Cornier MA, Dabelea D, Hernandez TL et al (2008) The metabolic syndrome. Endocrine reviews 29, 777-822
3. Cooper ST and McNeil PL (2015) Membrane Repair: Mechanisms and Pathophysiology. Physiol Rev 95, 1205-1240
4. Moller DE and Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Ann Rev Med 56, 45-62
5. Giacco F and Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107, 1058-1070
6. Cooper ST and Head SI (2015) Membrane Injury and Repair in the Muscular Dystrophies. Neuroscientist 21, 653-668
7. Barbee KA (2005) Mechanical cell injury. Ann N Y Acad Sci 1066, 67-84
8. Blazek AD, Paleo BJ and Weisleder N (2015) Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis. Physiology (Bethesda) 30, 438-448
9. Bansal D, Miyake K, Vogel SS et al (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423, 168-172
10. Doherty KR and McNally EM (2003) Repairing the tears: dysferlin in muscle membrane repair. Trends Mol Med 9, 327-330
11. Bazan NG, Marcheselli VL and Cole-Edwards K (2005) Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann N Y Acad Sci 1053, 137-147
12. Cai C, Masumiya H, Weisleder N et al (2009) MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11, 56-64
13. McNeil P (2009) Membrane repair redux: redox of MG53. Nat Cell Biol 11, 7-9
14. Cai C, Weislder N, Ko JK et al (2009) Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J Biol Chem 284, 15894-15902
15. Cao CM, Zhang Y, Weisleder N et al (2010) MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121, 2565-2574
16. He B, Tang RH, Weisleder N et al (2012) Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in delta-Sarcoglycan-deficient hamsters. Mol Ther 20, 727-735
17. Weisleder N, Takizawa N, Lin P et al (2012) Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med 4, 139ra85
18. Jia Y, Chen K, Lin P et al (2014) Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nat Commun 5, 4387
19. Zhang Y, Lv F, Jin L et al (2011) MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovas Res 91, 108-115
20. Liu J, Zhu H, Zheng Y et al (2015) Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. J Mol Cell Cardiol 80, 10-19
21. Zhou X, Chen M, Wang S, Yu L and Jiang H (2015) MG53 protein: a promising novel therapeutic target for myocardial ischemia reperfusion injury. Int J Cardiol 199, 424-425
22. Duann P, Li H, Lin P et al (2015) MG53-mediated cell membrane repair protects against acute kidney injury. Sci Transl Med 7, 279ra36
23. Lee CS, Yi JS, Jung SY et al (2010) TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell Death Differ 17, 1254-1265
24. Song R, Peng W, Zhang Y et al (2013) Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature 494, 375-379
25. Yi JS, Park JS, Ham YM et al (2013) MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun 4, 2354
26. Nguyen N, Yi JS, Park H, Lee JS and Ko YG (2014) Mitsugumin 53 (MG53) ligase ubiquitinates focal adhesion kinase during skeletal myogenesis. J Biol Cehm 289, 3209-3216
27. Weisleder N, Takeshima H and Ma J (2008) Immunoproteomic approach to excitation-contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins. Cell Calcium 43, 1-8
28. Weisleder N, Brotto M, Komazaki S et al (2006) Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol 174, 639-645
29. Weisleder N and Ma J (2008) Altered Ca2+ sparks in aging skeletal and cardiac muscle. Ageing Res Rev 7, 177-188
30. Zhao X, Weisleder N, Thornton A et al (2008) Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell 7, 561-568
31. Takeshima H, Shimuta M, Komazaki S et al (1998) Mitsugumin29, a novel synaptophysin family member from the triad junction in skeletal muscle. Biochem J 331 (Pt 1), 317-322
32. Pan Z, Yang D, Nagaraj RY et al (2002) Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nat Cell Biol 4, 379-383
33. Nagaraj RY, Nosek CM, Brotto MA et al (2000) Increased susceptibility to fatigue of slow-and fast-twitch muscles from mice lacking the MG29 gene. Physiol Genomics 4, 43-49
34. Pan Z, Hirata Y, Nagaraj RY et al (2004) Co-expression of MG29 and ryanodine receptor leads to apoptotic cell death: effect mediated by intracellular Ca2+ release. J Biol Chem 279, 19387-19390
35. Brotto MA, Nagaraj RY, Brotto LS et al (2004) Defective maintenance of intracellular Ca2+ homeostasis is linked to increased muscle fatigability in the MG29 null mice. Cell Res 14, 373-378
36. Kurebayashi N, Takeshima H, Nishi M et al (2003) Changes in Ca2+ handling in adult MG29-deficient skeletal muscle. Biochem Biophys Res Commun 310, 1266-1272
37. Yazawa M, Ferrante C, Feng J et al (2007) TRIC channels are essential for Ca2+ handling in intracellular stores. Nature 448, 78-82
38. Zhao X, Yamazaki D, Park KH et al (2010) Ca2+ overload and sarcoplasmic reticulum instability in tric-a null skeletal muscle. J Biol Chem 285, 37370-37376
39. Takeshima H, Komazaki S, Nishi M, Iino M and Kangawa K (2000) Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell 6, 11-22
40. Landstrom AP, Kellen CA, Dixit SS et al (2011) Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail 4, 214-223
41. Cai C, Masumiya H, Weisleder N et al (2009) MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem 284, 3314-3322
42. Jung SY and Ko YG (2010) TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2. Biochem Biophys Res Commun 396, 238-245
43. Ishikawa Y, Otsu K and Oshikawa J (2005) Caveolin; different roles for insulin signal? Cellular Signal 17, 1175-1182
44. Inokuchi J (2010) Membrane microdomains and insulin resistance. FEBS Lett 584, 1864-1871
45. Cohen AW, Razani B, Wang XB et al (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285, C222-235
46. Oshikawa J, Otsu K, Toya Y et al (2004) Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci U S A 101, 12670-12675
47. Liu L, Brown D, McKee M et al (2008) Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8, 310-317
48. Kim BW, Lee CS, Yi JS et al (2010) Lipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane. Expert Rev proteomics 7, 849-866
49. Saeki K, Miura Y, Aki D, Kurosaki T and Yoshimura A (2003) The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J 22, 3015-3026
50. Gupta N, Wollscheid B, Watts JD et al (2006) Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol 7, 625-633
51. Hill MM, Bastiani M, Luetterforst R et al (2008) PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124
52. Kim KB, Kim BW, Choo HJ et al (2009) Proteome analysis of adipocyte lipid rafts reveals that gC1qR plays essential roles in adipogenesis and insulin signal transduction. Proteomics 9, 2373-2382
53. Zhu H, Lin P, De G et al (2011) Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair. J Biol Chem 286, 12820-12824
54. Hatakeyama S (2011) TRIM proteins and cancer. Nat Rev Cancer 11, 792-804
55. Cai C, Lin P, Zhu H et al (2015) Zinc binding to MG53 protein facilitates repair of injury to cell membranes. J Biol Cehm 290, 13830-13839
56. Li H, Duann P, Lin PH et al (2015) Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair. J Biol Chem 290, 24592-24603
57. Hwang M, Ko JK, Weisleder N, Takeshima H and Ma J (2011) Redox-dependent oligomerization through a leucine zipper motif is essential for MG53-mediated cell membrane repair. Am J Physiol Cell Physiol 301, C106-114
58. Park EY, Kwon OB, Jeong BC et al (2010) Crystal structure of PRY-SPRY domain of human TRIM72. Proteins 78, 790-795
59. Bansal D and Campbell KP (2004) Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14, 206-213
60. McNeil PL and Kirchhausen T (2005) An emergency response team for membrane repair. Nat Rev Mol Cell Biol 6, 499-505
61. Weiler T, Bashir R, Anderson LV et al (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 8, 871-877
62. Saito A, Higuchi I, Nakagawa M et al (2002) Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma. Acta Neuropathol 104, 615-620
63. Glover L and Brown RH Jr (2007) Dysferlin in membrane trafficking and patch repair. Traffic 8, 785-794
64. Kim S, Seo J, Ko YG, Huh YD and Park H (2012) Lipid-binding properties of TRIM72. BMB Rep 45, 26-31
65. Lin P, Zhu H, Cai C et al (2012) Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J 26, 1875-1883
66. Kehrer JP and Klotz LO (2015) Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health. Crit Rev Toxicol 45, 765-798
67. Fischer R and Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev 2015, 610813
68. Wilson EM and Rotwein P (2006) Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II. J Biol Chem 281, 29962-29971
69. Serra C, Palacios D, Mozzetta C et al (2007) Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 28, 200-213
70. Potthoff MJ and Olson EN (2007) MEF2: a central regulator of diverse developmental programs. Develop 134, 4131-4140
71. Bassel-Duby R and Olson EN (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75, 19-37
72. Wu H, Naya FJ, McKinsey TA et al (2000) MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 19, 1963-1973
73. Potthoff MJ, Wu H, Arnold MA et al (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117, 2459-2467
74. Han R, Bansal D, Myiyake K et al (2007) Dysferlinmediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 117, 1805-1813
75. Wang X, Xie W, Zhang Y et al (2010) Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res 107, 76-83
76. Zhu H, Hou J, Roe JL et al (2015) Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein. Muscle Nerve 52, 852-858
77. Rommel C, Clarke BA, Zimmermann S et al (1999) Differentiation stage-specific inhibition of the Raf-MEKERK pathway by Akt. Science 286, 1738-1741
78. Goodman CA, Mayhew DL and Hornberger TA (2011) Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal 23, 1896-1906
79. Yao Y, Zhang B, Zhu H et al (2016) MG53 permeates through blood-brain barrier to protect ischemic brain injury. Oncotarget 7, 22474-22485
80. Burkin DJ and Wuebbles RD (2012) A molecular bandage for diseased muscle. Sci Transl Med 4, 139fs19
81. Ma H, Liu J, Bian Z et al (2015) Effect of metabolic syndrome on mitsugumin 53 expression and function. PLoS One 10, e0124128
82. Ma LL, Zhang FJ, Kong FJ et al (2013) Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3beta signals. Shock 40, 217-221
83. Xu Y, Ma LL, Zhou C et al (2013) Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One 8, e76652
84. Yuan H, Niu Y, Liu X et al (2013) Proteomic analysis of skeletal muscle in insulin-resistant mice: response to 6-week aerobic exercise. PLoS One 8, e53887
85. Terauchi Y, Iwamoto K, Tamemoto H et al (1997) Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99, 861-866
86. Tamemoto H, Kadowaki T, Tobe K et al (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186
87. Laustsen PG, Michael MD, Crute BE et al (2002) Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev 16, 3213-3222
88. Long YC, Cheng Z, Copps KD and White MF (2011) Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol Cell Biol 31, 430-441
89. Liu F, Song R, Feng Y et al (2015) Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha. Circulation 131, 795-804